Literature DB >> 8613695

Dendritic cells from different tissues induce production of different T cell cytokine profiles.

M P Everson1, D S McDuffie, D G Lemak, W J Koopman, J R McGhee, K W Beagley.   

Abstract

The precise role of antigen-presenting cells (APC) in regulating the balance of T-helper type 1 (Th1) and T-helper type 2 (Th2) cytokine production is unclear. Dendritic cells (DC), the most potent APC for activation of naive T cells, were found to regulate Th1 and Th2 cytokine profiles in a fashion dependent upon their tissue of origin. Spleen (systemic) DC induce mainly Th1 cytokines and Peyer's patch (mucosal) DC induce predominantly Th2 cytokines. These findings support the current concept that different tissues, each with its distinct microenvironment of cytokines, hormones, and cellular elements, are involved in the selection, promotion, and/or maintenance of different immune responses. With regard to DC, it is apparent that the tissue of DC origin determines the cytokine profiles produced by T cells and that DC from different tissues favor either cellular versus humoral immune responses by influencing T cell cytokine production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613695     DOI: 10.1002/jlb.59.4.494

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas.

Authors:  Y Chen; D L Boros
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 3.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 4.  Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

Authors:  R Hájek; A W Butch
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

5.  Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Authors:  Isabelle Dimier-Poisson; Fleur Aline; Marie-Noëlle Mévélec; Céline Beauvillain; Dominique Buzoni-Gatel; Daniel Bout
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

6.  Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.

Authors:  Natasa Obermajer; Urban Svajger; Mathew Bogyo; Matjaz Jeras; Janko Kos
Journal:  J Leukoc Biol       Date:  2008-08-13       Impact factor: 4.962

Review 7.  Current immunotherapeutic strategies for central nervous system tumors.

Authors:  Medina C Kushen; Adam M Sonabend; Maciej S Lesniak
Journal:  Surg Oncol Clin N Am       Date:  2007-10       Impact factor: 3.495

8.  The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.

Authors:  Bernhard M Kirsch; Maximilian Zeyda; Karl Stuhlmeier; Johannes Grisar; Josef S Smolen; Bruno Watschinger; Thomas M Stulnig; Walter H Hörl; Gerhard J Zlabinger; Marcus D Säemann
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

Review 9.  Biologic functions of the IFN-gamma receptors.

Authors:  G Tau; P Rothman
Journal:  Allergy       Date:  1999-12       Impact factor: 13.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.